Obinutuzumab Can Be Administered as a 90-minute Short Duration Infusion in Patients With Previously Untreated Follicular Lymphoma: GAZELLE End of Induction Analysis

• Miguel A. Canales,
• Thomas A. Buchholz,
• Jaisson A.P. Bortolini,
• Laura M. Fogliatto,
• Takayuki Ishikawa,
• Koji Izutsu,
• Antonio Salar,
• Jeff P. Sharman,
• Dirk Klingbiel,
• Sunny Pokala,
• Ekaterina Vorozheikina,
• Peter Trask,
• Joana Parreira,
• Kai Hübel

Affiliations

Miguel A. Canales

1 Hospital Universitario La Paz, Madrid, Spain

Thomas A. Buchholz

2 Scripps MD Anderson Cancer Center, San Diego, CA, USA

Jaisson A.P. Bortolini

3 Centro de Pesquisas Oncologicas, Florianopolis, Brazil

Laura M. Fogliatto

4 Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil

Takayuki Ishikawa

5 Kobe City Medical Center, General Hospital, Hyogo, Japan

Koji Izutsu

6 National Cancer Center Hospital, Tokyo, Japan

Antonio Salar

7 Hospital del Mar, Barcelona, Spain

Jeff P. Sharman

8 Willamette Valley Cancer Institute and Research Center, US Oncology Research, Eugene, OR, USA

Dirk Klingbiel

9 F. Hoffmann-La Roche Ltd, Basel, Switzerland

Sunny Pokala

9 F. Hoffmann-La Roche Ltd, Basel, Switzerland

Ekaterina Vorozheikina

10 IQVIA Medical and Scientific Services, Moscow, Russia

Peter Trask

11 Genentech, Inc., South San Francisco, CA, USA

Joana Parreira

9 F. Hoffmann-La Roche Ltd, Basel, Switzerland

Kai Hübel

12 Uniklinik Köln, Department I of Internal Medicine, Cologne, Germany